- Home
- PGEN vs REAL Comparison
PGEN vs REAL Comparison
Compare PGEN & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- REAL
- Stock Information
- Founded
- PGEN 1998
- REAL 2011
- Country
- PGEN United States
- REAL United States
- Employees
- PGEN N/A
- REAL N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- REAL Other Specialty Stores
- Sector
- PGEN Health Care
- REAL Consumer Discretionary
- Exchange
- PGEN Nasdaq
- REAL Nasdaq
- Market Cap
- PGEN 475.2M
- REAL 641.9M
- IPO Year
- PGEN N/A
- REAL 2019
- Fundamental
- Price
- PGEN $1.88
- REAL $5.10
- Analyst Decision
- PGEN Strong Buy
- REAL Buy
- Analyst Count
- PGEN 3
- REAL 5
- Target Price
- PGEN $6.00
- REAL $8.40
- AVG Volume (30 Days)
- PGEN 2.3M
- REAL 2.5M
- Earning Date
- PGEN 08-13-2025
- REAL 08-05-2025
- Dividend Yield
- PGEN N/A
- REAL N/A
- EPS Growth
- PGEN N/A
- REAL N/A
- EPS
- PGEN N/A
- REAL N/A
- Revenue
- PGEN $4,201,000.00
- REAL $616,717,000.00
- Revenue This Year
- PGEN $256.94
- REAL $11.70
- Revenue Next Year
- PGEN $759.81
- REAL $10.10
- P/E Ratio
- PGEN N/A
- REAL N/A
- Revenue Growth
- PGEN N/A
- REAL 11.89
- 52 Week Low
- PGEN $0.65
- REAL $2.24
- 52 Week High
- PGEN $2.17
- REAL $11.38
- Technical
- Relative Strength Index (RSI)
- PGEN 70.64
- REAL 45.84
- Support Level
- PGEN $1.81
- REAL $5.17
- Resistance Level
- PGEN $2.01
- REAL $5.56
- Average True Range (ATR)
- PGEN 0.12
- REAL 0.25
- MACD
- PGEN 0.04
- REAL 0.04
- Stochastic Oscillator
- PGEN 83.80
- REAL 46.78
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.